Table 1 Baseline characteristics of 121 acromegaly patients
From: The association between biochemical control and cardiovascular risk factors in acromegaly
All N = 121 | ||
|---|---|---|
Age, year | Mean | 55.4 |
(SD) | (16.7) | |
Agea at diagnosis, year | n | 109 |
Mean | 42.4 | |
(SD) | (15.0) | |
Female | n | 67 |
(%) | (55.4) | |
Race/ethnicity | ||
Caucasian | n | 88 |
(%) | (72.7) | |
Asian | n | 16 |
(%) | (13.2) | |
Hispanic | n | 12 |
(%) | (9.9) | |
Other | n | 5 |
(%) | (4.1) | |
Years of follow-up | Mean | 8.8 |
(SD) | (7.2) | |
25th percentile | 3.2 | |
Median | 5.8 | |
75th percentile | 13.7 | |
Tumor sizeb | n | 106 |
Macroadenoma | n | 93 |
(%) | (87.7) | |
Microadenoma | n | 13 |
(%) | (12.3) | |
Additional Hormonal Abnormalities | ||
Gonadal insufficiency | n | 20 |
(%) | (16.5) | |
Hypothyroidism | n | 19 |
(%) | (15.7) | |
Adrenal insufficiency | n | 18 |
(%) | (14.9) | |
Prolactin elevation | n | 1 |
(%) | (0.8) | |